Compare · CHEK vs GEHC
CHEK vs GEHC
Side-by-side comparison of Check-Cap Ltd. (CHEK) and GE HealthCare Technologies Inc. (GEHC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHEK and GEHC operate in Medical Electronics (Health Care), so they compete in similar markets.
- GEHC is the larger of the two at $29.42B, about 1383.3x CHEK ($21.3M).
- Over the past year, CHEK is up 100.6% and GEHC is down 9.9% - CHEK leads by 110.5 points.
- GEHC has hit the wire 7 times in the past 4 weeks while CHEK has been quiet.
- GEHC has more recent analyst coverage (25 ratings vs 1 for CHEK).
- Company
- Check-Cap Ltd.
- GE HealthCare Technologies Inc.
- Price
- $1.61+0.63%
- $64.58-0.12%
- Market cap
- $21.3M
- $29.42B
- 1M return
- +6.62%
- +5.30%
- 1Y return
- +100.62%
- -9.90%
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2015
- News (4w)
- 0
- 7
- Recent ratings
- 1
- 25
Check-Cap Ltd.
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based system that utilizes low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule, which is designed to measure, collect, and transmit structural information; C-Scan Track, a disposable system attached to the patient's back via biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis and report generation. The company was founded in 2004 and is based in Isfiya, Israel.
Latest CHEK
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- MBody AI and Check-Cap Enter into Definitive Merger Agreement
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 6-K filed by Check-Cap Ltd.
- SEC Form 20-F filed by Check-Cap Ltd.
- Check-Cap claims BMO's Chris Taves Illegally Attacks Israeli NASDAQ-Listed Company During Wartime
Latest GEHC
- GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities
- SEC Form SD filed by GE HealthCare Technologies Inc.
- Director Lobo Kevin bought $641,800 worth of shares (10,000 units at $64.18), increasing direct ownership by 229% to 14,363 units (SEC Form 4)
- GE HealthCare upgraded by UBS with a new price target
- CEO, AIS Rackliffe Philip was granted 16,458 shares, increasing direct ownership by 62% to 43,187 units (SEC Form 4)
- CEO, Patient Care Solutions Bankes Jeannette covered exercise/tax liability with 5,535 shares, decreasing direct ownership by 13% to 38,357 units (SEC Form 4) (tax withholding)
- Cardiac AI Diagnostics Stack Validation Wins Across Regulatory and Commercial Fronts
- Amendment: SEC Form SCHEDULE 13G/A filed by GE HealthCare Technologies Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by GE HealthCare Technologies Inc.
- Director Hochman Rodney F bought $100,365 worth of shares (1,618 units at $62.03) (SEC Form 4)